申高制药 (831332.OC)

+ 收藏

现金流量表(申高制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 4,603,455.5010,634,620.983,749,222.0810,238,933.213,491,281.20
 收到其他与经营活动有关的现金(元) 1,281,310.471,982,312.122,766,451.251,031,608.99860,774.85
 经营活动现金流入小计(元) 5,884,765.9712,616,933.106,515,673.3311,270,542.204,352,056.05
 购买商品、接受劳务支付的现金(元) 990,249.351,107,709.77603,028.49789,380.13325,693.28
 支付给职工以及为职工支付的现金(元) 3,150,880.725,817,060.403,194,507.565,431,833.312,902,558.93
 支付的各项税费(元) 594,722.901,324,698.12923,290.761,475,030.51207,166.88
 支付其他与经营活动有关的现金(元) 867,233.472,348,279.781,717,775.962,248,450.551,252,815.34
 经营活动现金流出小计(元) 5,603,086.4410,597,748.076,438,602.779,944,694.504,688,234.43
 经营活动产生的现金流量净额(元) 281,679.532,019,185.0377,070.561,325,847.70-336,178.38
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) 42,161.4926,911.5926,911.5935,882.1235,882.12
 投资活动现金流入小计(元) 42,161.4926,911.5926,911.5935,882.1235,882.12
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,236,748.57338,653.0348,241.004,590.007,900.00
 投资活动现金流出小计(元) 1,236,748.57338,653.0348,241.004,590.007,900.00
 投资活动产生的现金流量净额(元) -1,194,587.08-311,741.44-21,329.4131,292.1227,982.12
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 5,110,000.00690,000.00---
 筹资活动现金流入小计(元) 5,110,000.00690,000.00---
 偿还债务支付的现金(元) 5,110,000.001,380,000.00-1,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) 173,784.41372,618.50173,964.77463,116.03244,957.14
 支付其他与筹资活动有关的现金(元) --180,000.00--
 筹资活动现金流出小计(元) 5,283,784.411,752,618.50353,964.771,463,116.03244,957.14
 筹资活动产生的现金流量净额(元) -173,784.41-1,062,618.50-353,964.77-1,463,116.03-244,957.14
五、现金及现金等价物净增加额(元) -1,086,691.96644,825.09-298,223.62-105,976.21-553,153.40
 加:期初现金及现金等价物余额(元) 1,428,690.62783,865.53783,865.53889,841.74889,841.74
 期末现金及现金等价物余额(元) 341,998.661,428,690.62485,641.91783,865.53336,688.34
补充资料:
 净利润(元) -1,609,388.69329,256.19-583,886.92-3,284,502.72-2,544,082.93
 资产减值准备(元) 28,987.76134,122.6826,908.558,786.0014,854.10
 固定资产和投资性房地产折旧(元) 960,595.852,048,372.501,033,833.442,247,008.181,190,317.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 960,595.852,048,372.501,033,833.442,247,008.181,190,317.31
 无形资产摊销(元) 27,874.0255,748.0427,874.0255,748.0427,874.02
 长期待摊费用摊销(元) 19,714.534,900.88---
 递延收益摊销(元) -56,782.20-164,473.90---
 财务费用(元) 172,289.49372,284.67173,964.77452,275.63234,371.16
 投资损失(元) -42,161.49-26,911.59-26,911.59-35,882.12-35,882.12
 递延所得税(元) -80,695.65-137,575.40-75,649.93-86,065.0712,496.90
  其中:递延所得税资产减少(元) 4,169.174,552.678,299.2318,630.359,840.07
 递延所得税负债增加(元) -84,864.82-142,128.07-83,949.16-104,695.422,656.83
 存货的减少(元) -530,585.80-1,291,526.08-2,446,123.182,202,144.50-1,182,860.84
 经营性应收项目的减少(元) 2,635,750.28-1,804,085.33519,399.76-160,403.342,254,833.91
 经营性应付项目的增加(元) -1,243,918.572,499,072.371,509,898.3659,726.89-227,645.35
 其他(元) ---82,236.72-132,988.29-80,454.54
 现金的期末余额(元) 341,998.661,428,690.62485,641.91783,865.53336,688.34
 减:现金的期初余额(元) 1,428,690.62783,865.53783,865.53889,841.74889,841.74
 现金及现金等价物的净增加额(元) -1,086,691.96644,825.09-298,223.62-105,976.21-553,153.40
公告日期 2024-08-162024-04-192023-08-182023-04-202022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院